Associate Director, Global Health Economics and Outcomes Research
Acadia PharmaceuticalsSalary not specified
Full Time
Senior (5 to 8 years), Expert & Leadership (9+ years)
Director, Global HEOR - Oncology at Bristol-Myers Squibb
Princeton, New Jersey, United States
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, OncologyIndustries
Requirements
- An advanced degree (PhD/MD/PharmD/MS/MPH) in Health Economics, Outcomes Research, Econometrics, Epidemiology, Public Health or related discipline is highly preferred
- 6+ years of professional experience, with at least 3-5 years in the biopharmaceutical industry, or with a company that provides services to the biopharmaceutical industry
- Experience in executing an HEOR book of work and working in a matrix organization to support worldwide value access for a medicine is required
- An exemplary record of HEOR deliverables and peer-reviewed publications
- Experience managing patient registries or prospective observational studies is preferred
- Experience in supporting regulatory submissions is preferred
- Very strong written and verbal communication skills and be capable of distilling the essential elements of complex issues for senior internal and external stakeholders and scientific and non-scientific audiences alike
- Knowledge of oncology is strongly preferred
Responsibilities
- Develop worldwide health economic & outcomes research strategy to support BMS oncology products strategy and value proposition across early development to post launch lifecycle
- Design and execute HEOR studies with study concept, protocol, analysis plan, study report, data dissemination, for research including but not limited to systematic literature reviews, disease burden, patient reported outcomes, real-world treatment patterns and outcomes, economic modeling, prospective observational studies and comparative effectiveness studies in the oncology therapeutic area
- Engage and collaborate with oncology asset level matrix teams, including market access, clinical development, medical affairs, regulatory, biostatistics to ensure full alignment and integration HEOR evidence generation plan to support regulatory, market access and brand strategic imperatives and objectives
- Represent HEOR at cross-functional team matrix such as Development Team and Global Brand Team
- Develop and manage Global HEOR Book of Work to ensure optimal allocation and prioritization of budgetary resources to support oncology asset level objectives
- Ensure compliance with BMS SOPs and guidance in HEOR study conduct
- Maintain and develop strong partnership with external key opinion leaders in clinical, health economics, and outcomes research
- Manage prospective observational studies/patient registries as the Scientific Lead, as needed
Skills
Key technologies and capabilities for this role
Questions & Answers
Common questions about this position
What qualifications are required for the Director, Global HEOR - Oncology role?
An advanced degree (PhD/MD/PharmD/MS/MPH) in Health Economics, Outcomes Research, Econometrics, Epidemiology, Public Health or related discipline is highly preferred, along with 6+ years of professional experience including at least 3-5 years in the biopharmaceutical industry.
What experience is essential for this position?
Candidates need experience executing an HEOR book of work in a matrix organization to support worldwide value access for a medicine, an exemplary record of HEOR deliverables and peer-reviewed publications, and experience managing patient registries or prospective observational studies.
What is the salary range for this role?
This information is not specified in the job description.
Is this position remote or does it require office work?
This information is not specified in the job description.
What is the company culture like at Bristol Myers Squibb?
BMS offers a challenging, meaningful, and life-changing work environment with uniquely interesting work every day, opportunities to grow and thrive alongside high-achieving teams, and emphasizes balance and flexibility.
Bristol-Myers Squibb
Develops and delivers biopharmaceutical medicines
About Bristol-Myers Squibb
Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.
New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees